Zealand Pharma A/S (ZLDPF)
40.00
0.00 (0.00%)
USD |
OTCM |
Oct 05, 16:00
Zealand Pharma Profit Margin (Quarterly) : 87.22% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 87.22% |
| March 31, 2026 | -1.16K% |
| December 31, 2025 | -550.1% |
| September 30, 2025 | -815.5% |
| June 30, 2025 | 83.33% |
| March 31, 2025 | -4.14K% |
| December 31, 2024 | -3.21K% |
| September 30, 2024 | -6.03K% |
| June 30, 2024 | -857.7% |
| March 31, 2024 | -1.52K% |
| December 31, 2023 | -1.14K% |
| September 30, 2023 | 25.09% |
| June 30, 2023 | -3.07K% |
| March 31, 2023 | -1.42K% |
| December 31, 2022 | -1.34K% |
| September 30, 2022 | -347.4% |
| June 30, 2022 | -1.57K% |
| March 31, 2022 | -867.4% |
| December 31, 2021 | -1.57K% |
| September 30, 2021 | -261.0% |
| June 30, 2021 | -813.8% |
| March 31, 2021 | -4.25K% |
| December 31, 2020 | -600.6% |
| September 30, 2020 | -404.4% |
| June 30, 2020 | -26.32% |
| Date | Value |
|---|---|
| March 31, 2020 | -1.45K% |
| December 31, 2019 | -1.69K% |
| September 30, 2019 | -1.14K% |
| June 30, 2019 | -688.5% |
| March 31, 2019 | |
| December 31, 2018 | -937.4% |
| September 30, 2018 | |
| June 30, 2018 | -728.8% |
| March 31, 2018 | -1.00K% |
| December 31, 2017 | -1.05K% |
| September 30, 2017 | -110.3% |
| June 30, 2017 | -946.1% |
| March 31, 2017 | -33.92% |
| December 31, 2016 | 29.22% |
| September 30, 2016 | -78.07% |
| June 30, 2016 | -1.23K% |
| March 31, 2016 | -1.15K% |
| December 31, 2015 | 41.72% |
| September 30, 2015 | -715.8% |
| June 30, 2015 | -1.09K% |
| March 31, 2015 | -876.2% |
| December 31, 2014 | -998.9% |
| September 30, 2014 | 28.99% |
| June 30, 2014 | -1.11K% |
| March 31, 2014 | 33.94% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Genmab A/S | 26.23% |
| Ascendis Pharma A/S | 61.00% |
| Bavarian Nordic A/S | 36.03% |
| Evaxion AS | -- |
| ACADIA Pharmaceuticals, Inc. | 10.23% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 17.49% |
| Return on Assets | 15.97% |
| Return on Invested Capital | 17.05% |
| Gross Profit Margin (Quarterly) | 99.76% |
| Operating Margin (Quarterly) | 85.93% |
| Return on Net Operating Assets | 187.9% |